IN THE MATTER OF THE SECURITIES ACT R.S.O. 1990, c. S.5, AS AMENDED (the “Act”) AND IN THE MATTER OF BIOVAXYS TECHNOLOGY CORP. AND IN THE MATTER OF JAMES PASSIN (the “Respondent”)
TAKE NOTICE that the Director made an order under paragraphs 2 and 2.1 of subsection
127(1) of the Act and subsection 127 (4.1) of the Act that the Respondent cease trading in and
acquisitions of, whether direct or indirect, the securities of
BIOVAXYS TECHNOLOGY CORP.
until two full business days following the receipt by the Commission of all filings Biovaxys
Technology Corp. is required to make under Ontario securities law, or further order of the Director.
DATED at Toronto this 29th day of February, 2024.
Ontario Securities Commission
“Lina Creta”
Lina Creta
Manager, Corporate Finance Branch
CC: Odyssey Trust Company
IN THE MATTER OF THE SECURITIES ACT
R.S.O. 1990, c. S.5, AS AMENDED (the “Act”)
AND
IN THE MATTER OF
BIOVAXYS TECHNOLOGY CORP.
AND
IN THE MATTER OF
JAMES PASSIN
ORDER
(Paragraphs 2 and 2.1 of Subsection 127(1) and Subsection 127(4.1))
WHEREAS Biovaxys Technology Corp. (the “Reporting Issuer”) is a reporting issuer in
the Province of Ontario.
AND WHEREAS James Passin is a director, officer or other insider of the Reporting
Issuer and had, or may have had, access to material information with respect to the Reporting
Issuer that has not been generally disclosed.
AND WHEREAS the Reporting Issuer failed to file the following continuous disclosure
materials as required by Ontario securities law (collectively, the “Default”):
a) audited annual financial statements for the year ended October 31, 2023;
b) management’s discussion and analysis relating to the audited annual financial
statements for the year ended October 31, 2023; and
c) certification of the foregoing filings as required by National Instrument 52-109
Certification of Disclosure in Issuers’ Annual and Interim Filings;
AND WHEREAS the Director is of the opinion that it is in the public interest to make
this order;
IT IS ORDERED pursuant to paragraph 2 and paragraph 2.1 of subsection 127(1) and
subsection 127(4.1) of the Act that, effective immediately, all trading in and all acquisitions of
the securities of the Reporting Issuer, whether direct or indirect, by the Respondent shall cease
effective immediately
IT IS FURTHER ORDERED this order shall be revoked two full business days
following the receipt by the Commission of all filings the Reporting Issuer is required to make
under Ontario securities law, or further order of the Director.
IT IS FURTHER ORDERED under subsection 127(2) of the Act that, if the Reporting
Issuer has a website, this order shall be prominently posted on such website.
DATED at Toronto, this 29th day of February, 2024.
Ontario Securities Commission
“Lina Creta”
Lina Creta
Manager, Corporate Finance Branch
Revolutionizing treatment delivery